Notícias Daxor Corporation - DXR | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Daxor Corporation (DXR)
Daxor Corporation (DXR) Notícias

Daxor Corporation (DXR)

9,551

-0,34

(-3,43%)

Fechado 26 Novembro 6:00PM

Atrasado por 15 minutos

9,551

0,00

( 0,00% )

Pré-mercado: 9:00PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee

Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Form N-CSRS - Certified Shareholder Report, Semi-Annual

Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

Form N-2 - Registration statement for closed-end investment companies

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

BNP Paribas Issuance

BNP Paribas Issuance

MERCANTIL DO BRASIL PN

Invesco Defence Innovati...

Arterra Bioscience

OOOOO Entertainment Comm...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições